Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Volume makes cuts

.After bring up $213 thousand in 2023-- among the year's most extensive personal biotech rounds-- Vo...

BioMarin builds officer staff along with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings as...

Biopharma Q2 VC reached highest degree due to the fact that '22, while M&ampA slowed down

.Venture capital funding right into biopharma rose to $9.2 billion throughout 215 handle the 2nd qua...

Bicara, Zenas look for IPOs to press late-phase resources toward market

.Bicara Rehabs and Zenas Biopharma have provided fresh incentive to the IPO market along with filing...

Genentech to finalize cancer cells immunology study team

.Genentech is going to close its cancer immunology research study team, and also device head and als...

Kezar goes down sound tumor but to verify its own really worth in stage 1 test

.Kezar Lifestyle Sciences is falling its own unpromising period 1 strong cyst medicine as the biotec...

Acelyrin falls izokibep, lets go 3rd of workers

.Even with izokibep maintaining its newly found winning touch in the facility, Acelyrin is no more f...

Rivus' period 2 obesity-related cardiac arrest trial strikes endpoint

.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing medicine pros...

Ovid stops preclinical job, IV course after soticlestat fall short

.Ovid Therapeutics already exposed last month that it was trimming back its headcount as the busines...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Port, increasing its R...